...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Comparison of Salivary and Serum Soluble CD44 Levels between Patients with Oral SCC and Healthy Controls
【24h】

Comparison of Salivary and Serum Soluble CD44 Levels between Patients with Oral SCC and Healthy Controls

机译:口腔鳞状细胞癌患者和健康对照者唾液和血清可溶性CD44水平的比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: The most common type of oral cancer is oral squamous cell carcinoma. If it is diagnosed in the earlystages; the success of the treatment can be increased. It seems that ELISA-based techniques as a screening tool forsociety are the most cost-effective methods for early diagnosis. CD44 is a key marker for the detection of SCC stemcells. The aim of this study was to compare the level of soluble CD44 in saliva and serum between patients with oralSCC and healthy controls. Materials and Methods: Saliva and serum were collected from 20 patients with primaryOSCC and 20 healthy persons as control group. The samples were evaluated by an ELISA test kit. Data were analyzedby SPSS software version 22, chi-square, ANOVA, T-test and Spearman correlation test. Results: The mean of solubleCD44 level in serum and saliva of the patient and control groups are 531.51±228.95 and 453.3±113.74 (for serum)and 48.53±59.02 and 17.76±39.14 (for saliva) respectively. There was no statistically significant difference in serumand saliva solCD44 level between the patient and control groups (P value = 0.182 and P value = 0.061 respectively).Also, there was no significant correlation between the solCD44 level in each patient and control group in serum (Pvalue = 0.61) and in saliva (P value = 0.445). Conclusions: Determination of solCD44 level in saliva and serum canbe a useful method for diagnosis the person’s involvement with cancer cells and the cancer in the early stages. Butaccording to the controversial outcomes of past studies, larger and more accurate studies are needed in groups withmore cases of oral cancer.
机译:背景:最常见的口腔癌类型是口腔鳞状细胞癌。如果在早期被诊断出;可以增加治疗的成功率。似乎基于ELISA的技术作为社会筛查工具是早期诊断中最具成本效益的方法。 CD44是检测SCC干细胞的关键标志。这项研究的目的是比较口服SCC患者和健康对照者唾液和血清中可溶性CD44的水平。材料与方法:收集20例原发性OSCC患者和20例健康人的唾液和血清作为对照组。通过ELISA测试试剂盒评估样品。数据通过SPSS 22版软件,卡方检验,ANOVA,T检验和Spearman相关检验进行分析。结果:患者和对照组的血清和唾液中可溶性CD44水平的平均值分别为531.51±228.95和453.3±113.74(血清)和48.53±59.02和17.76±39.14(唾液)。患者和对照组之间的血清和唾液中solCD44水平无统计学差异(分别为P值= 0.182和P值= 0.061)。此外,每例患者和对照组的solCD44水平之间也无显着相关性( P值= 0.61)和唾液中(P值= 0.445)。结论:唾液和血清中solCD44水平的测定可能是诊断该人早期参与癌细胞和癌症的有用方法。但是,根据以往研究的有争议的结果,对于口腔癌病例更多的人群,需要进行更大,更准确的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号